Skip to content

Innovation

Anthony Rosenzweig, MD, chief of cardiology and co-director of the Corrigan Minehan Heart Center at MGH, describes a paradox at the center of heart disease. On the one hand, the last half-century has seen a dramatic drop in death rates among patients hospitalized for a heart attack. On the other hand, survivors often go on…

Read More

Influenza vaccination rates varied widely, especially by country, among patients with HF with reduced ejection fraction enrolled in the PARADIGM-HF trial. Vaccination in this population was associated with a reduced mortality risk, researchers reported in the Journal of the American College of Cardiology: Heart Failure. In the PARADIGM-HF trial, researchers compared valsartan/sacubitril (Entresto, Novartis) to…

Read More

Bioresorbable and biodegradable technology in stents along with iterative improvements in TAVR rounded out the top five “game-changers” in cardiology in 2015. Forty-six cardiologists responded to the question: “What is the research reported in 2015 that had the greatest impact on clinical practice,” and based on their responses here are the top five: 1. SPRINT…

Read More

Highlighting the Austens, a family whose innovations have revolutionized medical care and clinical research since the 1950s. For a fortunate few, vision isn't just one of the five senses. It's the predominant sense; it's a way of life. Vision is imagining a solution, already attained: What does it look like? How does it work? Where…

Read More

A look at Richard Lee, MD's research and discovery of GDF11 aimed at aging in the heart. When two prominent researchers meet for coffee, you never know what breakthrough medical advances might arise. Five years ago, Richard Lee, MD, a cardiologist at Brigham and Women's Hospital, and his good friend Harvard regenerative biologist Amy Wagers,…

Read More